Clinical trial
Lorazepam Sedation for Critically Ill Children
NCT00109395 · The Emmes Company, LLC, Industry · Completed
Key facts
| NCT number | NCT00109395 |
|---|---|
| Title | Lorazepam Sedation for Critically Ill Children |
| Official title | A Randomized Controlled Trial Comparing Lorazepam With Midazolam for Sedation of Mechanically Ventilated Pediatric Patients |
| Lead sponsor | The Emmes Company, LLC, Industry |
| Collaborators | Case Western Reserve University |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Critical Illness |
| Intervention type | Drug |
| Interventions | Lorazepam, Midazolam, Lorazepam CI |
| Enrollment | 179 |
| Start date | Sep 1, 2004 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Apr 28, 2005 |
| Last update posted | Mar 20, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: